{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-007750","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2025-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.236166+00:00","generated_at":"2026-05-17T02:28:43.653218+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sonoma Pharma terminates EVP/COO Bruce Thornton for cause, effective Oct 18","bullets":["Bruce Thornton terminated as EVP and Chief Operating Officer on October 18, 2025.","Termination was for cause under his employment agreement; no severance or future benefits.","Thornton will only receive salary and benefits earned through the termination date.","CEO Amy Trombly signed the 8-K confirming the departure."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-007750","json":"https://secwatch.observer/filing/0001683168-25-007750.json","markdown":"https://secwatch.observer/filing/0001683168-25-007750.md","text":"https://secwatch.observer/filing/0001683168-25-007750.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825007750/0001683168-25-007750-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825007750/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:28:43.653218+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}